Home › India's Ranbaxy gets FDA approval for Novartis's Diovan generic
 

Keywords :   


India's Ranbaxy gets FDA approval for Novartis's Diovan generic

2014-06-27 10:50:23| Chemicals - Topix.net

India's Ranbaxy Laboratories Ltd has received approval from the U.S. Food and Drug Administration to launch a cheaper copy of Novartis AG's blood pressure pill Diovan, bolstering its outlook after a raft of regulatory bans for poor production quality at its India facilities dented investor sentiment.

Tags: approval generic fda indias

Category:Chemicals

Latest from this category

All news
25.06Briolf Group to Invest $30 Million in Its First US Production Plant
25.06Sherwin-Williams Announces 2023 Water and Wastewater Impact Award Winners
25.06PPG Partners with ScieneFest Czechia
25.06PPG Partners with ScienceFest Czechia
25.06BASF Decides Against Investment in Nickel-cobalt Refining Complex in Indonesia
25.06Sto Breaks Ground on Manufacturing Facility in Mexico to Support Growth in the Region
25.06CCAI Presents 2024 Student Scholarships
24.06JOHNSTONES PAINT Brand by PPG to be Lead Sponsor of The Masters Snooker Tourney
Chemicals »
26.06Eastern North Pacific Tropical Weather Outlook
26.06Atlantic Tropical Weather Outlook
26.06Aer Lingus pilots begin industrial action over pay dispute
25.06Water requirements in the summer
25.06New model Is transforming the study of liver abscesses in cattle
25.06Royal Mail buyer to make offer for all staff shares
25.06World's biggest music labels sue over AI copyright
25.06Hybrid Software wins FLAG Vendor Partner of the Year award
More »